Aliases & Classifications for Anoxia

Aliases & Descriptions for Anoxia:

Name: Anoxia 51 69

Summaries for Anoxia

NINDS : 51 Cerebral hypoxia refers to a condition in which there is a decrease of oxygen supply to the brain even though there is adequate blood flow. Drowning, strangling, choking, suffocation, cardiac arrest, head trauma, carbon monoxide poisoning, and complications of general anesthesia can create conditions that can lead to cerebral hypoxia. Symptoms of mild cerebral hypoxia include inattentiveness, poor judgment, memory loss, and a decrease in motor coordination. Brain cells are extremely sensitive to oxygen deprivation and can begin to die within five minutes after oxygen supply has been cut off. When hypoxia lasts for longer periods of time, it can cause coma, seizures, and even brain death.  In brain death, there is no measurable activity in the brain, although cardiovascular function is preserved. Life support is required for respiration.

MalaCards based summary : Anoxia is related to cerebral hypoxia and acute mountain sickness, and has symptoms including anoxemia, cyanosis and dyspnea. An important gene associated with Anoxia is SOD1 (Superoxide Dismutase 1), and among its related pathways/superpathways are Folate Metabolism and Mechanisms of CFTR activation by S-nitrosoglutathione (normal and CF). The drugs Atropine and Succinylcholine have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and endothelial, and related phenotypes are Strongly decreased CFP-tsO45G cell surface transport and endocrine/exocrine gland

Wikipedia : 71 The term anoxia means a total depletion in the level of oxygen, an extreme form of hypoxia or \"low... more...

Related Diseases for Anoxia

Diseases related to Anoxia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 51)
id Related Disease Score Top Affiliating Genes
1 cerebral hypoxia 11.2
2 acute mountain sickness 10.8
3 dementia 10.8
4 neuronitis 10.4
5 hypoxia 10.3
6 cerebritis 10.3
7 endotheliitis 10.3
8 streptococcal meningitis 10.1 NOS2 SOD1
9 ectodermal dysplasia bartalos type 10.1 NOS2 SOD1
10 ischemia 10.1
11 pleural tuberculosis 10.1 SOD1 XDH
12 chromoblastomycosis 10.1 ICAM1 NOS2
13 myositis fibrosa 10.0 KCNJ5 SOD1
14 mucinous ovarian cystadenoma 9.9 ICAM1 NOS2 SOD1 XDH
15 cardiac arrest 9.8
16 status epilepticus 9.8
17 athetosis 9.7
18 glioblastoma 9.7
19 cerebral palsy 9.7
20 encephalopathy 9.7
21 hepatitis 9.7
22 hyperglycemia 9.6
23 persistent vegetative state 9.6
24 pertussis 9.6
25 akinetic mutism 9.6
26 audiogenic seizures 9.6
27 heart disease 9.6
28 retrograde amnesia 9.6
29 cortical blindness 9.6
30 dystonia 9.6
31 periventricular leukomalacia 9.6
32 hypoglycemia 9.6
33 hepatic encephalopathy 9.6
34 breast cancer 9.6
35 rett syndrome 9.6
36 melanoma 9.6
37 endocardial fibroelastosis 9.6
38 encephalomalacia 9.6
39 glioma 9.6
40 pulmonary hypertension 9.6
41 vaginitis 9.6
42 leukomalacia 9.6
43 brain injury 9.6
44 kernicterus 9.6
45 cerebral atrophy 9.6
46 brain ischemia 9.6
47 retinitis 9.6
48 malignant glioma 9.6
49 mutism 9.6
50 myoclonus 9.6

Graphical network of the top 20 diseases related to Anoxia:



Diseases related to Anoxia

Symptoms & Phenotypes for Anoxia

UMLS symptoms related to Anoxia:


anoxemia, cyanosis, dyspnea, signs and symptoms, respiratory, respiratory distress, labored breathing, symptoms

GenomeRNAi Phenotypes related to Anoxia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Strongly decreased CFP-tsO45G cell surface transport GR00360-A-2 8.92 ALDH9A1 CTGF EEF2K OXTR

MGI Mouse Phenotypes related to Anoxia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.8 EEF2K ICAM1 NOS2 OXTR SOD1 XDH
2 growth/size/body region MP:0005378 9.7 CTGF ICAM1 NOS2 OXTR SOD1 XDH
3 integument MP:0010771 9.5 ICAM1 NOS2 OXTR SOD1 XDH ALDH9A1
4 muscle MP:0005369 9.02 ICAM1 NOS2 OXTR SOD1 XDH

Drugs & Therapeutics for Anoxia

Drugs for Anoxia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 250)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
2
Succinylcholine Approved Phase 4 306-40-1 5314
3
Terbutaline Approved Phase 4 23031-25-6 5403
4
Bosentan Approved, Investigational Phase 4,Phase 1 147536-97-8 104865
5
Ipratropium Approved Phase 4 22254-24-6, 60205-81-4 43232
6
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
7
Budesonide Approved Phase 4 51333-22-3 63006 5281004
8
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
10
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
11
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
12
Metoprolol Approved, Investigational Phase 4 37350-58-6, 51384-51-1 4171
13
Nebivolol Approved, Investigational Phase 4 152520-56-4, 99200-09-6, 118457-14-0 71301
14
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
15
Alfentanil Approved, Illicit Phase 4 71195-58-9 51263
16
Lorazepam Approved Phase 4 846-49-1 3958
17
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
18
Etomidate Approved Phase 4 33125-97-2 36339 667484
19
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
20
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
21
Amlodipine Approved Phase 4 88150-42-9 2162
22
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
23 tannic acid Approved, Nutraceutical Phase 4
24
Maleic acid Experimental Phase 4 110-16-7 444266
25 Ether Phase 4
26 insulin Phase 4,Early Phase 1
27
Salmeterol xinafoate Phase 4 94749-08-3 56801
28 Tiotropium Bromide Phase 4 136310-93-5
29 Sildenafil Citrate Phase 4 171599-83-0
30
Beclomethasone Phase 4 4419-39-0 20469
31
Fluticasone Phase 4 90566-53-3, 80474-14-2 62924 22833648
32 Analgesics Phase 4,Phase 3,Phase 1,Phase 2
33 calcium channel blockers Phase 4,Phase 3
34 diuretics Phase 4,Phase 3,Phase 1,Phase 2
35 Muscarinic Antagonists Phase 4
36 Cholinergic Agents Phase 4
37 Adjuvants, Anesthesia Phase 4
38 Mydriatics Phase 4
39 Cholinergic Antagonists Phase 4
40 Narcotics Phase 4
41 Formoterol Fumarate Phase 4
42 Neuromuscular Agents Phase 4
43 Neuromuscular Blocking Agents Phase 4
44 Neuromuscular Depolarizing Agents Phase 4
45 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2
46 Adrenergic beta-Antagonists Phase 4
47 Albuterol Phase 4
48 Analgesics, Opioid Phase 4
49 Anesthetics Phase 4,Phase 3,Phase 1
50 Parasympatholytics Phase 4

Interventional clinical trials:

(show top 50) (show all 228)
id Name Status NCT ID Phase
1 CPAP in Liver Transplant Unknown status NCT00510770 Phase 4
2 Atropine Versus no Atropine for Neonatal Rapid Sequence Intubation Unknown status NCT01595399 Phase 4
3 Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery Unknown status NCT02133638 Phase 4
4 LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure Unknown status NCT00668408 Phase 4
5 Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia Unknown status NCT01449253 Phase 4
6 Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation. Completed NCT02593448 Phase 4
7 Optiflow® to Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery (the OPERA Trial) Completed NCT01887015 Phase 4
8 Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy Completed NCT01470170 Phase 4
9 Recruitment Maneuver After Intubation Completed NCT01014299 Phase 4
10 Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers Completed NCT01873612 Phase 4
11 Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation Completed NCT01692821 Phase 4
12 Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects. Completed NCT00924833 Phase 4
13 Preoxygenation Using NIV in Hypoxemic Patients Completed NCT00472160 Phase 4
14 Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea Completed NCT01377051 Phase 4
15 Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX) Recruiting NCT02589691 Phase 4
16 The Correlation Between Sleep Quality and Atrial Fibrillation Undergoing High-flow Nasal Cannula Oxygen (HFNC) Recruiting NCT02713737 Phase 4
17 Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study Active, not recruiting NCT01997515 Phase 4
18 Intermittent Hypoxia 2: Cardiovascular and Metabolism Active, not recruiting NCT02058823 Phase 4
19 Antenatal Allopurinol During Fetal Hypoxia Unknown status NCT00189007 Phase 3
20 Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma Unknown status NCT02089204 Phase 2, Phase 3
21 Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy Unknown status NCT01646619 Phase 3
22 Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion Completed NCT02247765 Phase 3
23 Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm Completed NCT01875159 Phase 3
24 Capnography During Percutaneous Transhepatic Cholangiodrainage (PTCD) (HepaBreath) Completed NCT01587157 Phase 3
25 Capnography During Colonoscopy Completed NCT01072487 Phase 3
26 Capnography During ERCP Completed NCT01072474 Phase 3
27 Using Capnography to Reduce Hypoxia During Pediatric Sedation Completed NCT01463527 Phase 3
28 Early Lactate-Directed Therapy in the Intensive Care Unit (ICU) Completed NCT00270673 Phase 3
29 Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants Completed NCT00152542 Phase 3
30 Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Completed NCT00000470 Phase 3
31 Evaluation of SC-V Versus Conventional CPR Completed NCT00000502 Phase 3
32 Efficacy of Fluoxetine Against Seizure-induced Central Apneas Completed NCT02569970 Phase 3
33 Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas Completed NCT00160095 Phase 3
34 Late Hypothermia for Hypoxic-Ischemic Encephalopathy Completed NCT00614744 Phase 2, Phase 3
35 PREoxygenation for the Intubation of Hypoxemic Patients: Comparison of Standard Oxygenation, High Flow Nasal Oxygen Therapy, and NonInvasive Ventilation Recruiting NCT01782430 Phase 2, Phase 3
36 Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT Recruiting NCT01212354 Phase 3
37 DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. Recruiting NCT02661152 Phase 3
38 The NEUROlogically-impaired Extubation Timing Trial Recruiting NCT02920580 Phase 3
39 Preemie Hypothermia for Neonatal Encephalopathy Recruiting NCT01793129 Phase 2, Phase 3
40 Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE) Terminated NCT01192776 Phase 3
41 Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer Unknown status NCT00388687 Phase 2
42 Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury Completed NCT00830453 Phase 2
43 Functional and Anatomical Magnetic Resonance Imaging (MRI) of Chronic Brain Injury and Hyperbaric Oxygen (HBO2) Study Subjects Completed NCT01126515 Phase 2
44 Advancement of Modified Bubble CPAP Completed NCT02208323 Phase 2
45 Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise Performance Completed NCT01871142 Phase 1, Phase 2
46 Rapid Acclimatization to Hypoxia at Altitude Completed NCT01702025 Phase 1, Phase 2
47 To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure Completed NCT00619606 Phase 2
48 Solar Powered Oxygen Delivery Completed NCT02100865 Phase 2
49 Rapamune Improves Outcomes of Severe H1N1 Pneumonia Completed NCT01620307 Phase 2
50 Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer Completed NCT01898065 Phase 2

Search NIH Clinical Center for Anoxia

Genetic Tests for Anoxia

Anatomical Context for Anoxia

MalaCards organs/tissues related to Anoxia:

39
Brain, Heart, Endothelial, Cortex, Neutrophil, Liver, Smooth Muscle

Publications for Anoxia

Articles related to Anoxia:

(show top 50) (show all 640)
id Title Authors Year
1
The Mitochondrial Unfolded Protein Response Protects against Anoxia in Caenorhabditis elegans. ( 27459203 )
2016
2
Deferoxamine improves antioxidative protection in the brain of neonatal rats: The role of anoxia and body temperature. ( 27297770 )
2016
3
Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy. ( 27011313 )
2016
4
Revealing how goldfish defy anoxia. ( 27207949 )
2016
5
Glycogen dynamics of crucian carp (Carassius carassius) in prolonged anoxia. ( 27272729 )
2016
6
Protective Effects of Isorhamnetin on Cardiomyocytes against Anoxia/ Reoxygenation-Induced Injury Is Mediated by SIRT1. ( 26859194 )
2016
7
Hypoxia and Anoxia Tolerance in the Annual Killifish Austrofundulus limnaeus. ( 27507238 )
2016
8
Water abstraction in small lowland streams: Unforeseen hypoxia and anoxia effects. ( 27295594 )
2016
9
Neonatal anoxia leads to time dependent progression of mitochondrial linked apoptosis in rat cortex and associated long term sensorimotor deficits. ( 27184438 )
2016
10
Carbohydrate metabolism in germinating caryopses of Oryza sativa L. exposed to prolonged anoxia. ( 27289587 )
2016
11
Rehabilitation following cerebral anoxia: An assessment of 27 patients. ( 26735867 )
2016
12
Mitochondrial DNA Sequence and Lack of Response to Anoxia in the Annual Killifish Austrofundulus limnaeus. ( 27630577 )
2016
13
Morphine-induced delayed pre-conditioning against anoxia/reoxygenation injury in pulmonary artery endothelial cells: The role of mitochondrial KATP channels. ( 26648415 )
2016
14
Timing of Locomotor Recovery from Anoxia Modulated by the White Gene in Drosophila. ( 27029736 )
2016
15
SAR11 bacteria linked to ocean anoxia and nitrogen loss. ( 27487207 )
2016
16
Mitochondrial responses to prolonged anoxia in brain of red-eared slider turtles. ( 26763217 )
2016
17
Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway. ( 27383330 )
2016
18
Assessment of anoxia tolerance and photoperiod dependence of GABAergic polarity in the pond snail Lymnaea stagnalis. ( 27664385 )
2016
19
Roles of catalase and glutathione peroxidase in the tolerance of a pulmonate gastropod to anoxia and reoxygenation. ( 27062029 )
2016
20
Modulating Peripheral Nerve Damage from Hyperglycemia/Anoxia. ( 27615362 )
2016
21
Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein. ( 27070866 )
2016
22
Comparative insights into mitochondrial adaptations to anoxia in brain. ( 27335547 )
2016
23
Marine anoxia and delayed Earth system recovery after the end-Permian extinction. ( 26884155 )
2016
24
The role of DNA methylation during anoxia tolerance in a freshwater turtle (Trachemys scripta elegans). ( 26843075 )
2016
25
Anoxia and glucose supplementation preserve neutrophil viability and function. ( 27402974 )
2016
26
Erythropoietin improves hypoxic-ischemic encephalopathy in Neonatal Rats after Short-term Anoxia by Enhancing Angiogenesis. ( 27659964 )
2016
27
Anti-apoptotic response during anoxia and recovery in a freeze-tolerant wood frog (Rana sylvatica). ( 27042393 )
2016
28
MicroRNAa89451 protects against cardiomyocyte anoxia/reoxygenation injury by inhibiting high mobility groupA boxA 1 expression. ( 27121079 )
2016
29
Anoxia and Acidosis Tolerance of the Heart in an Air-Breathing Fish (Pangasianodon hypophthalmus). ( 26658412 )
2015
30
Transcriptomic Responses of the Heart and Brain to Anoxia in the Western Painted Turtle. ( 26147940 )
2015
31
Patterns in nematode community during and after experimentally induced anoxia in the northern Adriatic Sea. ( 26322855 )
2015
32
Contribution of Opioid Receptors to the Cytoprotective Effect of the Adaptation to Chronic Hypoxia at Anoxia/Reoxygenation of Isolated Cardiomyocytes. ( 26085353 )
2015
33
Reversible brain swelling in crucian carp (Carassius carassius) and goldfish (Carassius auratus) in response to high external ammonia and anoxia. ( 25582543 )
2015
34
Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway. ( 25673186 )
2015
35
Acclimation of Hydrilla verticillata to sediment anoxia in vegetation restoration in eutrophic waters. ( 26423394 )
2015
36
Impact of neonatal anoxia on adult rat hippocampal volume, neurogenesis and behavior. ( 26416672 )
2015
37
Pushing the limit: Examining factors that affect anoxia tolerance in a single genotype of adult D. melanogaster. ( 25777190 )
2015
38
Genome-Wide Expression Profiling of Anoxia/Reoxygenation in Rat Cardiomyocytes Uncovers the Role of MitoKATP in Energy Homeostasis. ( 26171116 )
2015
39
Maternal Oxytocin Administration Before Birth Influences the Effects of Birth Anoxia on the Neonatal Rat Brain. ( 26108713 )
2015
40
Differential cytokine expression by brain microglia/macrophages in primary culture after oxygen glucose deprivation and their protective effects on astrocytes during anoxia. ( 25866619 )
2015
41
Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1. ( 26086862 )
2015
42
Chlamydomonas Flavodiiron Proteins Facilitate Acclimation to Anoxia During Sulfur Deprivation. ( 26063391 )
2015
43
Protective Effect and Mechanism of Total Flavones from Rhododendron simsii Planch Flower on Cultured Rat Cardiomyocytes with Anoxia and Reoxygenation. ( 25861370 )
2015
44
Inhibition of the mevalonate pathway ameliorates anoxia-induced down-regulation of FKBP12.6 and intracellular calcium handling dysfunction in H9c2 cells. ( 25636197 )
2015
45
Hippocampal cell death following neonatal anoxia: Functional consequences on spatial memory at adulthood. ( 26531502 )
2015
46
Naringin protects against anoxia/reoxygenation-induced apoptosis in H9c2 cells via the Nrf2 signaling pathway. ( 25773745 )
2015
47
The Involvement of Hydrogen-producing and ATP-dependent NADPH-consuming Pathways in Setting the Redox Poise in the Chloroplast of Chlamydomonas reinhardtii in Anoxia. ( 25691575 )
2015
48
Desflurane preconditioning protects human umbilical vein endothelial cells against anoxia/reoxygenation by upregulating NLRP12 and inhibiting non-canonical nuclear factor-I_B signaling. ( 26329693 )
2015
49
Newborn hypoxia/anoxia inhibits cardiomyocyte proliferation and decreases cardiomyocyte endowment in the developing heart: role of endothelin-1. ( 25692855 )
2015
50
Anoxia-induced changes in optimal substrate for peripheral nerve. ( 25451283 )
2015

Variations for Anoxia

Expression for Anoxia

Search GEO for disease gene expression data for Anoxia.

Pathways for Anoxia

GO Terms for Anoxia

Cellular components related to Anoxia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 peroxisome GO:0005777 8.92 ACOX1 NOS2 SOD1 XDH

Biological processes related to Anoxia according to GeneCards Suite gene sharing:

(show all 16)
id Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.72 ICAM1 OXTR SOD1
2 negative regulation of gene expression GO:0010629 9.58 CTGF NOS2 XDH
3 cellular response to interferon-gamma GO:0071346 9.56 ICAM1 NOS2
4 oxidation-reduction process GO:0055114 9.55 ACOX1 ALDH9A1 NOS2 SOD1 XDH
5 response to peptide hormone GO:0043434 9.54 CTGF OXTR
6 lactation GO:0007595 9.52 OXTR XDH
7 ovarian follicle development GO:0001541 9.51 ICAM1 SOD1
8 response to organic cyclic compound GO:0014070 9.5 CTGF ICAM1 OXTR
9 reactive oxygen species metabolic process GO:0072593 9.49 CTGF SOD1
10 response to amino acid GO:0043200 9.48 CTGF ICAM1
11 positive regulation of vasoconstriction GO:0045907 9.46 ICAM1 OXTR
12 cell aging GO:0007569 9.43 ICAM1 SOD1
13 superoxide metabolic process GO:0006801 9.37 NOS2 SOD1
14 response to copper ion GO:0046688 9.26 ICAM1 SOD1
15 response to anoxia GO:0034059 8.96 CTGF OXTR
16 response to amphetamine GO:0001975 8.8 ICAM1 OXTR SOD1

Molecular functions related to Anoxia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity GO:0016491 9.35 ACOX1 ALDH9A1 NOS2 SOD1 XDH
2 flavin adenine dinucleotide binding GO:0050660 8.8 ACOX1 NOS2 XDH

Sources for Anoxia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....